Form EFFECT Aclaris Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 31, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Starts Aclaris Therapeutis (ACRS) at Buy
- Lydian Clinic Announces Stem Cell Therapy for Orthopedic Conditions In Gangnam
- What Happens September 8? Apeing’s $0.0001 Presale Kicks Off the Hunt for the Next 100x Meme Coin
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
